North America systemic scleroderma treatment industry is dominating the global market for systemic scleroderma treatment, holding over 40% of the market share throughout forecast period. Favorable ...

The prevalence of T2D among a cohort of patients in Italy with SSc was lower than national estimates and associated with distinct vascular and cardiopulmonary features.

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of ...

Dianthus Therapeutics is offering Nanjing Leads Biolabs up to $1 billion biobucks for licensing rights to a bispecific antibody designed to treat certain autoimmune disorders. | Dianthus Therapeutics ...

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of ...

In a statement, Cabaletta CEO Steven Nichtberger, M.D., highlighted Gavel’s previous experience commercializing cell ...

Quoin Pharmaceuticals ( ($QNRX) ) has shared an update. On October 10, 2025, Quoin Pharmaceuticals announced a private placement agreement with ...

Kris Aquino has slammed another death hoax about her saying she's currently in isolation amid her battle with multiple ...

Clinical Laboratory Services Market: The clinical laboratory services market will grow from $297.5 Bn in 2025 to $396.8 Bn by ...

Sanofi says that its experimental drug amlitelimab has the potential to become a ‘best-in-class’ maintenance therapy for atopic dermatitis (AD) after reporting new phase 2b data. The latest results ...

A new study from South Korea has found that a common type of diabetes medicine may offer an unexpected benefit: a lower risk ...